Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03315065 · ClinicalTrials.gov registry record · Early Phase 1
19F Thoracic Radiotherapy for Lung Cancer
A Early Phase 1 study, sponsored by Hal C Charles.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 6
- Enrollment target
NCT03315065: Completed Early Phase 1 study, sponsored by Hal C Charles.
NCT03315065 is a Early Phase 1 study that has completed, run by Hal C Charles. The registered enrollment target is 6 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03315065, a Early Phase 1 study, has completed, sponsored by Hal C Charles.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The goal of this study is to determine the feasibility and efficiency of incorporating 19F MR functional lung imaging into the routine assessment of lung cancer patients prior to thoracic radiotherapy.
Interventions
- DRUG Perfluorinated Gas/Oxygen Mixture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2018-02-16 |
| Est. Completion | 2019-06-25 |
| Phase | Early Phase 1 |
What the finished NCT03315065 record still lists
NCT03315065 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which Perfluorinated Gas/Oxygen Mixture is the first listed.
NCT03315065 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03315065 about?
NCT03315065 is a clinical study titled "19F Thoracic Radiotherapy for Lung Cancer". The goal of this study is to determine the feasibility and efficiency of incorporating 19F MR functional lung imaging into the routine assessment of lung cancer patients prior to thoracic radiotherapy.
What is the current status of trial NCT03315065?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 6 participants. The study started on 2018-02-16. Estimated completion is 2019-06-25.
What interventions are being tested in trial NCT03315065?
The interventions under investigation include: Perfluorinated Gas/Oxygen Mixture (DRUG).
Who is sponsoring clinical trial NCT03315065?
This trial is sponsored by Hal C Charles, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03315065's enrollment target sits among peer trials
6 1846th of 2000 higher than 114 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI